Synthetic Oligonucleotides with Certain Palindromes Stimulate Interferon Production of Human Peripheral Blood Lymphocytes in vitro

Japanese Journal of Cancer Research

Volumn 85, Issue 8, 1994, Pages 775-779

  Yamamoto, Toshiko ^a   Yamamoto, Saburo ^a   Kataoka, Tetsuro ^a   Komuro, Katsutoshi ^a   Kohase, Masayoshi ^a   Tokunaga, Tohru ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Human PBL; IFN production; Palindrome; Synthetic oligoDNA

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INTERFERON; OLIGONUCLEOTIDE; PALINDROMIC DNA; SINGLE STRANDED DNA;

ARTICLE; BIOASSAY; CELL CULTURE; CULTURE MEDIUM; DNA SEQUENCE; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; LYMPHOCYTE; PRIORITY JOURNAL;

BASE SEQUENCE; CELLS, CULTURED; HUMAN; INTERFERON INDUCERS; INTERFERON TYPE II; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERONS; KINETICS; LYMPHOCYTES; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0027978749     PISSN: 09105050     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1994.tb02947.x     Document Type: Article

References (19)

1. In vitro augmentation of NK activity of peripheral blood cells from cancer patients by a DNA fraction from M
2. Studies on lymphocyte subsets of regional lymph nodes after endoscopic injection of biological response modifiers in gastric cancer patients
3. Late‐stage phase‐II clinical study of MY‐1 in treatment on malignant cutaneous tumors
4. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity
5. Antitumor activity of deoxyribonucleic acid from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors
6. In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG
7. In vitro augmentation of natural killer cell activity and production of interferon‐α/β and ‐γ with deoxyribonucleic acid fraction from Mycobacterium bovis BCG
8. In situ infiltration of natural killer cells induced by intradermal injection of the nucleic acid fraction from BCG
9. Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells
10. Characterization, sequence determination and immunogenicity of a 64 kilodalton protein of Mycobacterium bovis BCG expressed in E. coli K 12
11. Cloning of a species‐specific antigen of Mycobacterium bovis
12. Cloning and expression of the Mycobacterium bovis BCG gene for extracellular antigen
13. Antitumor activity of synthetic oligonucleotides with sequences from cDNA encoding proteins of Mycobacterium bovis BCG
14. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN‐mediated natural killer activity
15. Ability of oligonucleotides with certain palindromes to induce IFN production and augment NK activity is associated with their base length
16. Potency standardization of human interferon preparation for clinical trials
17. DNA binding to human leukocytes. Evidence for receptormediated association, internalization, and degradation of DNA
18. Mechanism of oligonucleotide uptake by cells: involvement of specific receptors
19. Type I macrophage scavenger receptor contains alpha‐helical and collagen‐like coiled coils